Physician
Gulf Coast Pathology Program PLLC
Gulf Coast Pathology Program PLLC was paid $455K by Medicaid between Jul 2021 and Dec 2024, across 141 billing codes. Its largest line is 88307, — 41% of everything it billed.
33Billing provider infoGULF COAST PATHOLOGY PROGRAM PLLC
HOUSTON, TX 77004
HOUSTON, TX 77004
33aNPI1629643069assigned 05/26/2021
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$455K
24GClaims821,118
24DCodes billed141
24AFirst – last monthJul 2021 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Texas
Rank by total paid#16 of 97
Median peer was paid$24K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 67,321 | $52K | |
| 2022 | 216,942 | $132K | |
| 2023 | 293,578 | $169K | |
| 2024incomplete | 243,277 | $102K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88307 | 41% | 4,351 | 3,585 | $187K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 37% | 4,637 | 3,850 | $168K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.6% | 27,429 | 25,910 | $16K |
| 88304 | 1.9% | 1,145 | 1,028 | $9K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 27,512 | 17,832 | $7K |
| 88342 | 1.1% | 236 | 224 | $5K | |
| 82805 | 1.0% | 5,377 | 2,163 | $5K | |
| 85027 | <1% | 120,555 | 62,983 | $4K | |
| 84112 | <1% | 1,184 | 1,065 | $4K | |
| 80053 | Comprehensive metabolic panel | <1% | 43,821 | 28,338 | $3K |
| 82803 | <1% | 4,275 | 1,564 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 73,819 | 37,293 | $2K |
129 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 10,473 | $2K |
| 88302 | <1% | 344 | $2K | |
| 82247 | <1% | 12,851 | $2K | |
| 86780 | <1% | 5,059 | $2K | |
| 86803 | <1% | 2,102 | $2K | |
| 86850 | <1% | 12,730 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,596 | $2K |
| 82248 | <1% | 8,308 | $2K | |
| 86900 | <1% | 25,182 | $1K | |
| 87400 | <1% | 16,272 | $1K | |
| 86703 | <1% | 6,611 | $1K | |
| 86901 | <1% | 22,287 | $1K | |
| 87340 | <1% | 6,330 | $1K | |
| 84484 | <1% | 23,790 | $1K | |
| 86880 | <1% | 3,661 | $968.45 | |
| 81025 | <1% | 11,592 | $897.27 | |
| 83880 | <1% | 7,541 | $896.73 | |
| 87040 | <1% | 10,719 | $880.01 | |
| 81001 | <1% | 27,623 | $794.52 | |
| 84702 | <1% | 5,923 | $783.58 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,876 | $741.73 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 9,822 | $741.13 |
| 80076 | <1% | 22,619 | $739.81 | |
| 87081 | <1% | 6,034 | $704.77 | |
| 83605 | <1% | 13,521 | $647.31 | |
| 83690 | <1% | 17,051 | $646.47 | |
| 87807 | <1% | 3,844 | $594.00 | |
| 88300 | <1% | 98 | $500.98 | |
| 82947 | <1% | 2,331 | $470.58 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,536 | $407.10 |
| 83735 | <1% | 24,849 | $401.16 | |
| 87806 | <1% | 1,410 | $393.63 | |
| 84703 | <1% | 7,128 | $372.88 | |
| 87634 | <1% | 1,240 | $350.30 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 449 | $350.10 |
| 85014 | <1% | 5,481 | $319.67 | |
| 85060 | <1% | 27 | $313.91 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,061 | $292.56 |
| 86756 | <1% | 984 | $279.63 | |
| 80320 | <1% | 2,114 | $253.89 | |
| 85018 | <1% | 4,105 | $248.19 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,039 | $239.80 |
| 88312 | <1% | 33 | $237.54 | |
| 84100 | <1% | 11,643 | $232.22 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 8,314 | $229.58 |
| 81003 | <1% | 22,038 | $204.60 | |
| 80306 | <1% | 746 | $191.52 | |
| 87186 | <1% | 3,139 | $189.34 | |
| 85610 | <1% | 14,641 | $171.07 | |
| 85379 | <1% | 1,360 | $169.79 | |
| 85730 | <1% | 10,903 | $168.20 | |
| 80061 | Lipid panel | <1% | 5,201 | $149.55 |
| 87070 | <1% | 2,786 | $121.98 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,089 | $112.04 |
| 86140 | <1% | 1,335 | $106.77 | |
| 83615 | <1% | 718 | $106.29 | |
| 87420 | <1% | 1,490 | $99.90 | |
| 87430 | <1% | 5,158 | $97.42 | |
| 86885 | <1% | 3,632 | $87.12 | |
| 82570 | <1% | 843 | $82.60 | |
| 87077 | <1% | 1,605 | $66.54 | |
| 80329 | <1% | 1,072 | $65.97 | |
| 82550 | <1% | 2,437 | $65.64 | |
| 84550 | <1% | 1,154 | $65.36 | |
| 85007 | <1% | 1,367 | $63.63 | |
| 85044 | <1% | 655 | $63.18 | |
| 80143 | <1% | 954 | $62.64 | |
| 82150 | <1% | 1,316 | $46.53 | |
| 87205 | <1% | 2,921 | $42.44 | |
| 80305 | <1% | 899 | $41.79 | |
| 88313 | <1% | 80 | $36.44 | |
| 86592 | <1% | 3,086 | $35.90 | |
| 87641 | <1% | 577 | $34.19 | |
| 87088 | <1% | 2,672 | $34.00 | |
| 82330 | <1% | 258 | $29.16 | |
| 80047 | <1% | 941 | $28.42 | |
| 82565 | <1% | 1,981 | $25.80 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,885 | $25.62 |
| 87390 | <1% | 547 | $20.21 | |
| 84132 | <1% | 678 | $15.20 | |
| 86141 | <1% | 360 | $10.88 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 285 | $10.47 |
| 85378 | <1% | 611 | $9.86 | |
| 84460 | <1% | 367 | $8.90 | |
| 84030 | <1% | 412 | $8.78 | |
| 84450 | <1% | 385 | $8.70 | |
| 85651 | <1% | 91 | $7.18 | |
| 84520 | <1% | 438 | $6.64 | |
| 85049 | <1% | 618 | $3.57 | |
| 84156 | <1% | 561 | $2.93 | |
| 85652 | <1% | 244 | $2.27 | |
| 86762 | 0% | 409 | $0.00 | |
| 86920 | 0% | 325 | $0.00 | |
| 82746 | 0% | 128 | $0.00 | |
| 86738 | 0% | 73 | $0.00 | |
| 82607 | 0% | 279 | $0.00 | |
| 82077 | 0% | 466 | $0.00 | |
| 86921 | 0% | 20 | $0.00 | |
| 86701 | 0% | 397 | $0.00 | |
| 82950 | 0% | 563 | $0.00 | |
| 84479 | 0% | 114 | $0.00 | |
| 82728 | 0% | 173 | $0.00 | |
| 82553 | 0% | 84 | $0.00 | |
| 86403 | 0% | 30 | $0.00 | |
| 83550 | 0% | 171 | $0.00 | |
| 84436 | 0% | 162 | $0.00 | |
| 82952 | 0% | 44 | $0.00 | |
| 82951 | 0% | 55 | $0.00 | |
| 84300 | 0% | 14 | $0.00 | |
| 87507 | 0% | 29 | $0.00 | |
| 84075 | 0% | 18 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 13 | $0.00 |
| 87501 | 0% | 114 | $0.00 | |
| 80321 | 0% | 281 | $0.00 | |
| 82140 | 0% | 403 | $0.00 | |
| 80202 | 0% | 232 | $0.00 | |
| 85384 | 0% | 523 | $0.00 | |
| 81002 | 0% | 856 | $0.00 | |
| 84481 | 0% | 75 | $0.00 | |
| 83540 | 0% | 230 | $0.00 | |
| 86923 | 0% | 15 | $0.00 | |
| 80179 | 0% | 18 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 13 | $0.00 |
| 82310 | 0% | 12 | $0.00 | |
| 82010 | 0% | 12 | $0.00 | |
| 85045 | 0% | 30 | $0.00 | |
| 86922 | 0% | 20 | $0.00 | |
| 84439 | 0% | 222 | $0.00 | |
| 84295 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKORDONOWY, WADE (DIVISION VP)